DCLK1 is Overexpressed and Associated with Immune Cell Infiltration in Hepatocellular Carcinoma
Author:
Funder
Consejo Nacional de Ciencia y Tecnología
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine,Ecology, Evolution, Behavior and Systematics,Biochemistry
Link
https://link.springer.com/content/pdf/10.1007/s10528-024-10667-y.pdf
Reference50 articles.
1. Anwanwan D, Singh SK, Singh S, Saikam V, Singh R (2020) Challenges in liver cancer and possible treatment approaches. Biochim et Biophys acta Reviews cancer 1873(1):188314–188314. https://doi.org/10.1016/j.bbcan.2019.188314
2. Bayik D, Lathia JD (2021) Cancer stem cell-immune cell crosstalk in tumour progression. Nat Rev Cancer 21(8):526–536. https://doi.org/10.1038/s41568-021-00366-w
3. Broner EC, Trujillo JA, Korzinkin M, Subbannayya T, Agrawal N, Ozerov IV, Izumchenko E (2021) Doublecortin-like kinase 1 (DCLK1) is a Novel NOTCH Pathway Signaling Regulator in Head and Neck Squamous Cell Carcinoma. Front Oncol 11:677051
4. Cao L, Cheng H, Jiang Q, Li H, Wu Z (2020a) APEX1 is a novel diagnostic and prognostic biomarker for hepatocellular carcinoma. Aging 12(5):4573–4591. https://doi.org/10.18632/aging.102913
5. Cao Z, Weygant N, Chandrakesan P, Houchen CW, Peng J, Qu D (2020b) Tuft and cancer stem cell marker DCLK1: a new target to enhance anti-tumor immunity in the tumor microenvironment. Cancers (Basel) 12(12):3801. https://doi.org/10.3390/cancers12123801
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3